Andrea Babians-Brunner

Successful Use of Omalizumab in an Inadequately Controlled Type 2 Diabetic Patient With Severe Insulin Allergy

P. Schmid‐Grendelmeier, M. Donath, C. Cavelti-Weder, 2012, Diabetes Care.

Inhibition of IL-1β Improves Fatigue in Type 2 Diabetes

H. Gast, I. Penner, M. Donath, 2011, Diabetes Care.

Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes

M. Donath, C. Dinarello, T. Mandrup-Poulsen, 2012, Diabetes Care.